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Abstract
Background: Inpatient case fatality from severe malaria remains high in much of sub-Saharan Africa. The majority of these
deaths occur within 24 hours of admission, suggesting that pre-hospital management may have an impact on the risk of
case fatality.
Methods: Prospective cohort study, including questionnaire about pre-hospital treatment, of all 437 patients admitted with
severe febrile illness (presumed to be severe malaria) to the paediatric ward in Sikasso Regional Hospital, Mali, in a two-
month period.
Findings: The case fatality rate was 17.4%. Coma, hypoglycaemia and respiratory distress at admission were associated with
significantly higher mortality. In multiple logistic regression models and in a survival analysis to examine pre-admission risk
factors for case fatality, the only consistent and significant risk factor was sex. Girls were twice as likely to die as boys (AOR
2.00, 95% CI 1.08–3.70). There was a wide variety of pre-hospital treatments used, both modern and traditional. None had a
consistent impact on the risk of death across different analyses. Reported use of traditional treatments was not associated
with post-admission outcome.
Interpretation: Aside from well-recognised markers of severity, the main risk factor for death in this study was female sex,
but this study cannot determine the reason why. Differences in pre-hospital treatments were not associated with case
fatality.
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Introduction
Inpatient case fatality from severe malaria remains high in
much of sub-Saharan Africa and since 2004 reports range from
2.35% to 11% [1,2,3,4]. The majority of these deaths occur within
24 hours of admission, suggesting that pre-hospital management
may have an impact on the risk of case fatality. Nevertheless, most
studies have considered only clinical risk factors for death
[1,2,3,4,5]; only a few have examined risk factors pertaining to
pre-hospital management and found that delay to first treatment
and use of chloroquine were associated with increased case fatality
[6,7].
In Mali, a community-based cross-sectional survey collecting
retrospective data on 212 cases of presumed severe malaria in
2002 revealed that overall mortality was 17.0% (95% CI 12.2–
22.7%). It did not differ significantly according to whether the
patients received modern or traditional treatment [8]. Sixty-six
different traditional herbal medicines were reportedly used for the
treatment of malaria in this survey, of which one was selected for
clinical trials and yielded promising results [9,10,11,12]. In 2005
the official first-line treatment for malaria changed from chloro-
quine to ACTs (Artemisinin Combination Therapies: artesunate-
amodiaquine and artemether-lumefantrine). The recommendation
had been in force for one year at the time of this study (2006), and
ACTs were supposed to be available within the public health
system.
This study aimed to investigate the previous findings, and
whether the change in treatment policy had made a difference.
The objective was to identify pre-hospital risk factors for death
from severe febrile illness (presumed severe malaria) in children.
Methods
Ethics statement
The study protocol was reviewed and approved by the
institutional ethics committee of the Institut National de Recher-
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che en Santé Publique, Bamako, Mali. Parents or guardians were
informed about the study and were asked for their written consent,
which was given for all cases included in the study.
Study site
The study was conducted in Sikasso Hospital, in South-East
Mali. Sikasso is the second largest town in Mali, and the hospital
covers a population of approximately 2 million people, predom-
inantly rural. Malaria is endemic in this area with seasonal
transmission during the rainy season (July – November). One
study in this area showed that 87% of febrile patients in the rainy
season were positive for malaria parasites [13].
An internal audit in 2002 revealed that the inpatient case
fatality rate in the paediatric ward was 24.3% (151 deaths out of
621 admissions), with 64 deaths (42.4%) attributed to malaria.
Changes were then made, to have a stock of essential medications
(including artemether and 10% glucose) on the ward to enable
immediate treatment and to provide blood transfusions as rapidly
as possible. During the present study, all inpatients with presumed
severe malaria were treated according to local consensus
guidelines [14]. The first-line parenteral antimalarial was intra-
muscular artemether, followed by artesunate/amodiaquine once
the patient was able to swallow. This is because staffing levels were
insufficient to permit adequate supervision of 8-hourly quinine
infusions. Blood glucose was evaluated with a portable glucometer
on admission and hypoglycaemia was treated. Intravenous
ceftriaxone was prescribed for all comatose patients, and all
patients with repeated convulsions underwent a lumbar puncture
to investigate for meningitis. Staff were advised to avoid non-
essential and non-evidence-based medications such as vitamins,
steroids, and intravenous paracetamol. Emergency medications
and medical equipment were made available on the paediatric
ward so that treatment could start immediately on arrival of the
patient.
Staff were motivated through participation in the development
and implementation of the guidelines, regular meetings to discuss
progress and difficult cases; and small bonus payments to
compensate for extra work. User fees were waived for participants
during the study period. The care provided to the patients in
hospital was not influenced by patients’ ability to pay. Therefore
we could explore how differences in outcome were influenced by
differences in pre-hospital care, controlling for differences in
severity at the time of admission.
Participants
All children presenting to the Paediatric Department of Sikasso
Hospital with a clinical diagnosis of severe malaria (according to
the admitting physician) from 28th September to 30th November
2006 were invited to participate. This was a prospective
consecutive sample during the peak malaria season. Patients with
no parasites seen on blood films were not excluded, so as not to
bias the sample (because pre-admission antimalarials may make it
harder to find parasites). We were careful to collect information on
all patients, even those who died within a short time of admission.
Data collection
Patients were clinically assessed, treated and stabilised as soon as
possible after admission. As soon as the patient was stable, one of
the interns interviewed the parent(s) or guardian of the patient
using a structured questionnaire. Parents were asked about the
duration of the illness before presenting to hospital; whether the
patient had received any pre-hospital treatment before or after the
malaria became severe, who had given this, and what the
treatment was. Patients were also shown a photograph and sample
of two plants commonly used for the treatment of malaria to ask
whether they recognised them and whether they had used them to
treat this illness. We had to rely on information given by parents
because in most cases there were no written records. Patients were
then followed prospectively until discharge from hospital or death.
Statistical analysis
Data were entered using the customised data entry facility of
Epi-info 6.04 (CDC, Atlanta, GA, USA) and analysed with Stata
version 10.0 (Stata Corporation, College Station, TX, USA) and R
statistical software (http://www.r-project.org). Descriptive statis-
tics were computed for demographic characteristics, clinical
features, pre-hospitalization malaria treatments and subsequent
interventions. We examined the risk factors for death according to
univariate analyses and to a logistic regression model. The model
was adjusted for variables which were thought to be associated
with mortality, including demographics, clinical baseline features,
indicators of severe malaria and treatments. All variables were thus
kept in the logistic regression, including those which were not
statistically significant in univariate analyses.
A survival analysis was then carried out to test the robustness of
our findings. Survival curves were estimated using the Kaplan-
Meier method and differences in the curves were explored using
the log-rank test. The inter-relationship of possible pre-hospital
risk factors and survival was analysed using a Cox Proportional
Hazards model, focusing on drug treatments received prior to
hospital admission, patient demographic factors, duration of
illness, and measures of the severity of the illness on arrival at
the hospital. Interactions were included for weight and age, and
modern and traditional treatment. Weight, age, the duration of
illness and the time taken to travel to the hospital were log
transformed to improve model fit. Multivariate selection of key risk
factors was carried out using a stepwise procedure. For the
purposes of the analytic model, patients who were discharged
‘‘cured’’ by the doctors were assumed to have survived for the
duration of the study period. There were 12 patients who self-
discharged without consent from a doctor and their survival was
only assumed up to the point of discharge. In a sensitivity analysis,
we verified that similar results were obtained (data not shown)
when survival of those discharged ‘‘cured’’ was only assumed up to
time of discharge. The assumption of proportional hazards over
time was checked for all covariates.
Results
There were a total of 453 admissions to the paediatric ward
during the study period, of whom 437 (96%) were presumed to
have severe malaria and were included in the study. None of the
patients refused to participate. Their mean age was 3.5 years, 243
(55.6%) were boys, and 366 (83.8%) were aged 5 years or less.
69.5% had an interpretable blood film, of which 20% were
negative for malaria parasites. 290 (66.4%) came from Sikasso
town itself, while the rest came from the surrounding areas. The
majority of children (287) had had at least one episode of
uncomplicated malaria since the end of the last rainy season (range
0–7, median 1). 48 children had had at least one previous episode
of severe malaria since the last rainy season.
The final outcomes are summarised in Table 1. The case
fatality rate was 17.4%. Twelve patients were lost to follow-up or
self-discharged before completion of treatment, and these were
excluded from subsequent analyses, leaving a sample size of 425
patients in whom the outcome of the illness was known. Of the
deaths, 34% occurred before any treatment was administered,
12% occurred less than one hour after admission, 59% occurred
Risk Factors for Death from Severe Febrile Illness
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less than 12 hours after admission, and 86% occurred less than
24 hours after admission. There were no further deaths after
82 hours.
The final diagnosis at discharge remained severe malaria in 432
patients (98.9%), and 55 (12.6%) had an additional diagnosis. The
most frequent comorbidity was a respiratory infection (24 cases),
followed by meningitis (9) and typhoid (4). Figure 1 shows the
number of patients with each subtype of severe malaria (some
patients had more than one). The commonest features at
admission were severe anaemia and convulsions, but case fatality
in these groups was relatively low. Conversely coma, hypoglycae-
mia and respiratory distress at admission were more unusual but
associated with significantly higher mortality (35%, 47% and 53%
respectively, P,0.0001), which was confirmed in the logistic
regression and survival analysis.
Of the 425 patients for whom an outcome was available, 145
(34%) had been referred to the hospital from primary health care
centres in the surrounding town and region, and the rest self-
presented spontaneously. Case fatality was not significantly
different between those who had been referred (15.9%) compared
to those who had self-presented (18.9%, p = 0.6), or between those
who came from the town (19.0%) or those who came from
surrounding villages (13.8%). We had information on the time
taken to travel to hospital for 85 patients. For these patients, those
who died had arrived in hospital significantly faster (mean of 45
minutes) compared to those who survived (mean of 90 minutes,
p = 0.03). The mean reported duration of illness prior to admission
was 3.7 days in patients who died and 3.9 days in patients who
survived.
340 patients (82.5%) had taken some form of treatment before
coming to hospital, mostly while they only had symptoms of
uncomplicated malaria, before developing symptoms of severe
malaria (335 patients). No pre-hospital treatment had been given
to 72 patients, and in 13 cases the respondent did not know
Table 1. Outcomes in the cohort of patients followed prospectively.
Outcome Female (n) Male (n) Total (n) Percent of total
Cured without sequelae 139 201 340 77.6
Deceased 45 31 76 17.4
Cured with sequelae 4 5 9 2.1
Self-discharged 6 6 12 2.7
Total 194 243 437 100
doi:10.1371/journal.pone.0102530.t001
Figure 1. Number of patients with different features of severe malaria, and risk of death in each subgroup.
doi:10.1371/journal.pone.0102530.g001
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whether or not the patient had received any such treatment. Pre-
hospital treatment was more often given to boys (86.5%) compared
to girls (77.5%, p = 0.01), although the type of treatment did not
differ significantly according to sex. In over half the cases who
received a treatment, this was given by the family (table 2). Case
fatality did not differ significantly according to type of provider.
Only 68 patients received a treatment from a second provider, and
6 from a third provider, before coming to hospital. The
commonest second provider was a health centre.
In multiple logistic regression models, the only consistent and
significant pre-hospital risk factor for case fatality was sex. Girls
were twice as likely to die as boys: of 188 girls, 45 died (23.8%),
compared to 31 of 237 boys (13.1%). This difference remained
significant irrespective of age, position in the family, home location
(urban or rural), type of pre-hospital treatment, clinical features at
admission, or duration of disease before admission (table 3). Mean
reported duration of illness prior to hospitalisation was actually
shorter for girls (3.5 days) than for boys (4.2 days), and girls were
more likely to die within 12 hours of arrival than boys. Coma,
respiratory distress and low blood glucose were all associated with
significantly greater odds of case fatality. Malnutrition and positive
blood films for plasmodia did not alter the results. The same results
were obtained when including only those with positive blood films.
Among the children who died, 69% of girls died in less than
12 hours, compared to 45% of boys (p = 0.04). Survival analysis
confirmed that girls had a significantly lower chance of survival
compared to boys (X2 = 8.56, df = 1, p,0.01 by the log-rank
test, see figure 2).
A second multiple logistic regression examined the effect of
different types of pre-hospital treatment. A wide range of modern
medications was taken pre-hospital, and there was an even wider
range of traditional treatments (62 different herbal remedies were
reported). The number of different modern treatments taken per
patient was one in the majority (n = 127), two in 41 patients, three
in 12 patients and four in one patient. The number of treatments
taken did not affect case fatality. Apart from the broad categories
of traditional only, modern only, or both, we also examined the
effect of the antimalarial treatments taken by the largest numbers
of people, namely chloroquine (n = 76), quinine (n = 68), amodi-
aquine (n = 44), co-trimoxazole (n = 31) and artemisinin deriva-
tives or combination therapies (n = 21). In the unadjusted analysis,
case fatality was reduced in those who had taken only modern
treatments (OR 0.49, 95% CI 0.25–0.95), in those who had taken
chloroquine in combination with traditional treatments (OR 0.17,
95% CI 0.04–0.77), and in those who had taken modern
treatments other than quinine or amodiaquine. However all of
these ceased to be significant in the adjusted analysis, in which the
lowest risk of case fatality was in those who had taken chloroquine
in combination with a traditional remedy (AOR 0.18, 95% CI
0.03–1.13), and the greatest risk of case fatality was in those who
had taken amodiaquine only (AOR 2.36, 95% CI 0.67–8.29).
There was also a trend towards lower case fatality for those who
had taken chloroquine only, an artemisinin derivative, or co-
trimoxazole, but this did not reach statistical significance, probably
because of the low absolute number of patients having taken these
treatments. Treatment with amodiaquine or quinine was not
associated with a reduction in case fatality.
Regarding the traditional remedies, the majority were reported
only once so no analysis is possible. On direct questioning, 17
patients recognised a specimen of Argemone mexicana and
reported its use for this illness. They had taken it for 2–4 days
(mean 2.6 days) and 6 had only taken it once a day (mean 1.7
times daily). It was not associated with a reduced case fatality in
this sample.
134 patients (34.5%) took some treatment after the malaria had
become severe. Of these 79 had taken a modern treatment only,
23 had taken a traditional treatment only, and 32 had taken both.
In these cases the traditional treatments were associated with the
lowest case fatality (13.0%) compared to the modern (15.2%) or
both (21.9%).
On survival analysis, chloroquine was the only drug to reveal
any difference in the survival rates by the log-rank test (X2 = 4.32,
df = 1, p = 0.04). However, when looking at the first 24 hours
post hospital admission this drug effect is no longer evident,
whereas the features of severe malaria and sex remain significant.
Pre-hospital treatment with modern medicine significantly im-
proved survival in this analysis (X2 = 4.11, df = 1, p = 0.04).
Assuming the last known survival time was after the observation
period (rather than time of hospital discharge) had little difference
on the model. Stepwise selection of variables produced the
reduced Cox Proportional Hazards model in table 4. This is
broadly consistent with the findings of the regression analysis.
Patients who had been pre-treated with cotrimoxazole or
paracetamol were at lower risk of death, whereas those who had
received amodiaquine were at higher risk of death.
We also tested our assumption that patients had all received an
equally good standard of care in hospital by checking whether they
had been prescribed treatments according to the protocol and
Table 2. Type of pre-hospital treatment(s) taken before malaria became severe, according to provider of first treatment
(N = number of patients).
Provider of first treatment Type of treatment: Overall N (%) Case fatality
Modern only Traditional only Both
Family 57 51 79 187 (45.4%) 31 (16.6%)
Health Centre 83 1 17 101 (24.5%) 16 (15.8%)
Private health professional 19 1 6 26 (6.3%) 4 (15.4%)
Traditional Healer 0 10 6 16 (3.9%) 2 (12.5%)
Street medicine vendor 1 0 3 4 (1.0%) 0 (0%)
Chinese medicine 1 0 0 1 (0.2%) 1 (100%)
None 0 0 0 77 (18.7%) 18 (23.4%)
Overall N (%) 161 (48.1%) 63 (18.8%) 111 (33.1%) 412 72 (17.5%)
Case Fatality 22 (13.7%) 15 (23.8%) 17 (15.3%)
doi:10.1371/journal.pone.0102530.t002
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whether the treatment had been given. The same proportion of
patients were prescribed the correct medications, and there was no
barrier to receiving treatment since it was provided free of charge
on the ward. 10 girls and 6 boys died before receiving any
treatment (reflecting the more rapid rate of death in girls). Ten
patients (of 122) who had been prescribed a blood transfusion did
not receive one, and eight of these were girls (odds ratio for a girl
receiving a transfusion compared to a boy = 0.17, 95% CI 0.02–
0.91). Numbers were insufficient for inclusion in the model. Of the
8 girls who did not receive a transfusion, 5 died, one was lost to
follow-up and two survived. Of the two boys, one died and one
survived. Of the 10 children who did not receive transfusions, 6
died. Looking just at the children who died, 17 had been
prescribed a transfusion, which was received by 11 (4 of 5 boys and
7 of 12 girls). This does explain part but not all of the sex
difference in death rates. Even excluding these deaths, there is a
significant excess of female deaths. Sensitivity analyses demon-
strated that the difference between boys and girls remains even
with the lack-of-transfusion deaths removed.
Discussion
Principle findings
As 86% of deaths occurred within 24 hours of admission, pre-
hospital treatment is likely to have the biggest impact on reducing
case fatality. The commonest pre-hospital treatments were
traditional (n = 174), paracetamol (144), chloroquine (76) and
quinine (68). These were all widely available at the time of the
study. However none of the pre-hospital treatments had an effect
which reached statistical significance in the adjusted logistic
regression model. It is possible that some of these effects would
become statistically significant with a larger sample size, as the
number of patients having taken any particular treatment was
relatively small. Furthermore no information is available about
Figure 2. Probability of survival for 420 children with suspected malaria (males n = 233, females n = 187), truncated at 100 hours.
doi:10.1371/journal.pone.0102530.g002
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dose, duration, compliance, sequence and quality of the
treatments. Traditional treatments did not significantly alter the
effect of modern treatments (OR 0.88 ‘‘modern only’’ versus 0.77
‘‘both treatments’’ as compared to ‘‘no treatment’’). The extreme
diversity of different treatments and combinations (modern-
modern, traditional-modern) shows that official treatment recom-
mendations were not followed most of the time. Although
chloroquine is no longer recommended as a treatment for malaria
in Mali, it seemed to be more protective than amodiaquine, which
has been increasingly used as monotherapy when ACTs are out of
stock. This may have led to an increase in amodiaquine resistance
which may explain why this treatment alone seemed the least
effective. It is interesting that co-trimoxazole seemed protective, as
it has both antimalarial and antibiotic properties.
The major factor associated with survival was sex: the case
fatality rate in girls was twice that in boys, even after adjusting for
all the other risk factors we could think of. Data on duration of
illness prior to hospitalisation and time to death imply that girls
deteriorated faster than boys. Retrospective data from hospital
records did not reveal the same discrepancy between the sexes.
Hospital policy was to exclude from their statistics those patients
who died before receiving treatment. In our cohort we were
particularly careful to include all children who arrived in the
paediatric department with severe febrile illness (even if they died
very soon after arrival), and of these, twice as many girls as boys
were excluded from the official statistics. Other studies which have
not attempted to include all patients may therefore have missed a
difference in mortality between the sexes [15]. Demographic and
Health Survey data on infant mortality in Mali found that male
Table 3. Logistic Regression model of risk factors for case fatality, including socio-demographic variables, pre-hospital treatment,
and clinical features at hospitalisation.
Variables n (%) OR (95% CI)
Sex
Male 237 (13.1) 1 (ref1)
Female 188 (23.9) 2.00 (1.08–3.70)*
Age
#1 101 (17.8) 1 (ref)
2–3 160 (21.3) 1.00 (0.44–2.24)
$4 164 (14.6) 0.96 (0.40–2.27)
Sibling position
1 68 (14.7) 1 (ref)
2 72 (16.7) 0.67 (0.22–2.05)
3 66 (21.2) 1.83 (0.64–5.22)
$4 216 (17.1) 1.21 (0.49–3.00)
Town-dweller (Sikasso)
No 138 (13.9) 1 (ref)
Yes 284 (19.0) 1.72 (0.87–3.40)
Previous treatment
None 90 (24.4) 1 (ref)
Traditional only 63 (23.8) 1.74 (0.66–4.63)
Modern only 161 (13.7) 0.88 (0.38–2.06)
Both 111 (15.3) 0.77 (0.31–1.90)
Coma
No 360 (12.5) 1 (ref)
Yes 62 (45.2) 6.08 (2.96–12.49)***
Respiratory distress
No 296 (11.1) 1 (ref)
Yes 126 (31.7) 3.75 (2.00–7.03)***
Baseline glycaemia
$80 g/L 360 (12.2) 1 (ref)
,80 g/L 65 (49.2) 7.22 (3.54–14.71)***
Disease duration
1 day 28 (10.7) 1 (ref)
2 days 70 (17.7) 2.61 (0.49–13.99)
$3 days 324 (17.9) 2.26 (0.48–10.65)
1Ref = reference.
* p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0102530.t003
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infants were at greater risk of death from malaria than female
infants [16]; but this trend may be reversed for older children.
Sociological factors are the most obvious explanation for the
difference in survival, for example girls might be less well
nourished, and have less resources spent on them (for treatment)
than boys in a male-dominated society. Indeed the fact that this
cohort included significantly more boys than girls (55.6% vs
44.4%) suggests that families are more likely to bring boys to
hospital than girls, because there is no reason to believe that
incidence of severe malaria is greater in boys than in girls. Girls
may only be brought to hospital when they are more seriously ill
than is the case for boys. The only significant differences we could
find between management of boys and girls in our dataset was that
boys were slightly more likely to have received a pre-hospital
treatment (although the type of treatment did not differ), and more
likely to receive a transfusion when it was prescribed. These are
important findings and should be investigated further, but they do
not fully explain the large observed difference in case fatality.
There was no significant association in any of the models
between case fatality and reported pre-hospital duration of illness,
or treatment provider. Traditional treatments did not significantly
worsen prognosis, and may indeed have improved prognosis when
taken together with chloroquine. It would be interesting to
research this further, as there are indications that some herbal
medicines can reverse resistance to chloroquine [17]. These
findings differ from those of other studies; in Sudan it was found
that delay in seeking treatment was a risk factor for mortality [7].
A study in Nigeria found that chloroquine was associated with a
worse prognosis [6]. Some studies claim that that patients
consulting traditional healers or taking traditional medicines have
a worse outcome [18] but this is not borne out by our findings.
Since most patients (64%) presented at the hospital after a disease
duration of three days or more, it was not statistically possible to
assess the possible protective effect of an early presentation. The
odds ratio for death in children presenting three or more days after
the start of illness had a wide confidence interval (OR 2.26, 95%
CI 0.48–10.65). Furthermore living in Sikasso town (relatively
close to the hospital) and a short time of travel to the hospital were
associated with a worse prognosis, implying that patients with
rapidly progressive illness from further afield die before arriving at
the hospital.
Mortality was greatest for patients with respiratory distress,
hypoglycaemia or coma. The effect of hypoglycaemia is discussed
in more detail in a separate paper [14]. These findings agree with
the results of other studies [5,19,20]. We investigated the
treatment of hypoglycaemia with sublingual sugar in a separate
study [21], but did not implement the findings in this study
(infusions of intravenous glucose were used as per the consensus
guidelines). It is possible that pre-hospital use of sublingual sugar
on a routine basis could further reduce mortality in patients with
hypoglycaemia.
Strengths and weaknesses of the study
This is one of the first studies to examine the impact of pre-
hospital treatment on case fatality for children admitted with
severe malaria. We made every effort to implement a best-practice
standard protocol for inpatient management of severe malaria,
and treatment was given free of charge. This may otherwise have
been an important confounding factor as poorer patients may not
have been able to afford the full treatment. Comparison with
hospital statistics from previous years suggests that this interven-
tion in itself reduced case fatality below the previous level
(although the inclusion criteria were not directly comparable).
Another study has shown that an intervention to improve quality
of care in the hospital, and to make care free of charge, can reduce
inpatient case fatality [22]. However we were unable to completely
standardise blood transfusion, because no patient can receive a
transfusion until a relative or friend has donated blood and our
data suggests that it was harder to find blood donors for girls than
for boys.
The fact that we recruited only hospitalised patients means that
the sample is biased, because the majority of patients with severe
malaria do not present to hospital [8]. However we believe that
more patients presented than usual, because fees for treatment
were waived. The number of malaria admissions was greater than
in the previous malaria season. All those included represent a
failure of pre-hospital treatment, which should aim to prevent not
only death but also severe malaria. Therefore community studies
would be better for estimating the effectiveness of treatments in the
whole population. However such studies would have to be
extremely large to gather information on the relatively small
proportion of deaths. Even in this study of 425 patients, the
number in each treatment sub-category was small because of the
high diversity of treatments used, so there was insufficient power to
detect differences between individual treatments with confidence
and statistical significance.
The diagnosis was left to the admitting physician, without
defining precise criteria for ‘‘severe malaria’’. Almost every severe
Table 4. Variables in the Cox Proportional Hazards model after stepwise selection, assuming that all patients discharged ‘‘cured’’
survived until the end of the observational period.
Multivariate proportional hazards Lower CI Upper CI P-Value
log(weight in kg) 0.48 0.22 1.03 0.06
Coma 5.12 3.06 8.58 0.00
Low blood glucose (,4.4 mmol/l) 4.62 2.81 7.59 0.00
Respiratory Distress 2.76 1.67 4.55 0.00
Amodiaquine taken 2.02 0.93 4.37 0.08
Cotrimoxazole taken 0.24 0.06 1.01 0.05
Paracetamol taken 0.54 0.31 0.94 0.03
Log (Time taken to travel to hospital, in minutes) 0.54 0.40 0.74 0.00
Female sex 1.72 1.06 2.79 0.03
CI = confidence interval.
doi:10.1371/journal.pone.0102530.t004
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febrile illness was labelled as ‘‘severe malaria’’, and the diagnosis at
discharge was still ‘‘severe malaria’’ in all but 4 patients. A study in
the community at the same time found that 87% of patients
presenting with symptoms of fever had a blood film positive for
malaria [13]. Although the population is not strictly comparable,
the rate of over-diagnosis was probably ,15%.
There is a risk that answers to the questionnaire may not have
been accurate, because the patient’s relatives may have feared
criticism, or because they were not fully aware of the treatment
taken, or simply because their memory was imperfect. The history
was taken at admission, although for some cases it was not possible
to take the history before the patient died (as 34% died less than
one hour after arrival). In 16.2% of the cases, the respondent was
not one of the parents of the child. The fact that the study took
place in a hospital, and the questionnaire was administered by an
intern, may have influenced the replies. We relied on the memory
and honesty of parents and did not verify the drug history through
urine testing, so we have no information on compliance or quality
of the drugs taken. It is possible that some of them may have been
of poor quality, out of date, or counterfeit. As this is an
observational study, ‘‘confounding by indication’’ cannot be
excluded, even while controlling for many clinical factors. It is
also impossible to accurately standardise the time from symptom
onset to arrival at hospital.
Meaning of the study
These findings have several implications for public health
policies. In spite of the improvements we made to hospital care,
the majority of deaths occurred within a short time of admission. It
seems that, like meningitis in European settings, the infection can
progress very rapidly from a seemingly innocuous prodrome, and
can unexpectedly become severe. We did not ask care-givers how
long after the start of the illness they gave the first treatment, and
this would be interesting to include in future studies. However it
seems logical that the earlier an effective treatment is given, the
better the outcome should be.
As the first source of treatment was the family in over 55% of
cases, parents and families need training on when and how to
administer ‘‘home-based management of malaria’’. This could be
delivered alongside interventions to prevent childhood diseases,
such as vaccination and distribution of insecticide-treated bednets.
Efficacy alone is not sufficient to prevent death; effective
treatments must be widely available, for girls as well as for boys.
Unanswered questions and future research
Further research is needed to show whether a concerted and
integrated intervention in home-based prevention and manage-
ment of childhood febrile illness can indeed reduce case fatality,
and how all treatment providers can collaborate to make this a
reality. There is a lot of scope for further research on traditional
medicines, and for their improvement. As hypoglycaemia is also
an important risk factor for death, early administration of sugar
may also be important [14]. Further studies are needed to
investigate compliance with different treatments, determinants of
choice, and treatment sequence. It would also be useful to collect
information on severity of symptoms before hospitalisation.
Further research is needed to clarify why the case fatality was
twice as high in girls as in boys, whether this finding is more widely
generalisable to other settings, and what interventions could be
envisaged to address this inequality. Higher case fatality in girls
with severe malaria has also been noticed in a similar study in
Gabon [1] and in Ghana it has been reported that girls are more
likely to be treated at home, whereas boys are more likely to be
taken to a health facility [23].
Although improvements in quality of care at the hospital can
reduce inpatient case fatality, the real challenge is to investigate
how these improvements can be sustained beyond the period of
the research study, and how capacity can be increased to meet the
increased demand for hospital treatment. This will probably
require continued motivation of staff through regular audit or
‘‘significant event analysis’’, and possibly a degree of external
supervision, as well as additional financial and human resources.
Conclusion
Aside from well-recognised markers of severity, the main risk
factor for death in this study was female sex, which could be a
proxy for other socio-cultural determinants. Differences in pre-
hospital treatments were not associated with case fatality in this
study.
Acknowledgments
We would like to thank all the staff of the paediatric department at Sikasso
hospital for their enthusiastic collaboration and hard work on this project,
in particular Dr Jian Min Tong, the interns Moussa N. Dembele, Lamine
Bagayogo, the ward sister and the nursing staff. We would like to thank the
patients and their parents for their collaboration. We are grateful to the
hospital, regional and national health authorities for supporting this work.
In particular Dr Georges Dakono, then head of the national malaria
control programme, donated mosquito nets to be given to each patient on
discharge. We are grateful to the PSDS Office in Sikasso, Dr Bernard
Lambert, Victoria Lopez and Amandine Schaller for their help at the start
of the study, and to Dr Alison Ward, Dr Jason Oke, Dr Richard Stevens,
Dr Richard Mayon-White and Dr Dan Lasserson for helpful comments on
the article.
Author Contributions
Conceived and designed the experiments: MLW BG MID JF CD SG DD
ED. Performed the experiments: MLW MID ED. Analyzed the data: MF
BS MLW BG. Contributed reagents/materials/analysis tools: JF SG.
Wrote the paper: MLW MF BS BG. Obtained ethical approval: CD DD.
Data entry: MID. Read and approved final manuscript: MLW MID BG JF
CD SG DD ED BS MF.
References
1. Dzeing-Ella A, Nze Obiang PC, Tchoua R, Planche T, Mboza B, et al. (2005)
Severe falciparum malaria in Gabonese children: clinical and laboratory
features. Malaria Journal 4: 1.
2. Ehrhardt S, Mockenhaupt FP, Anemana SD, Otchwemah RN, Wichmann D, et
al. (2005) High levels of circulating cardiac proteins indicate cardiac impairment
in African children with severe Plasmodium falciparum malaria. Microbes &
Infection 7: 1204–1210.
3. Issifou S, Kendjo E, Missinou MA, Matsiegui PB, Dzeing-Ella A, et al. (2007)
Differences in presentation of severe malaria in urban and rural Gabon.
American Journal of Tropical Medicine & Hygiene 77: 1015–1019.
4. Bassat Q, Guinovart C, Sigauque B, Aide P, Sacarlal J, et al. (2008) Malaria in
rural Mozambique. Part II: children admitted to hospital. Malaria Journal 7: 37.
5. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995)
Indicators of life-threatening malaria in African children. [see comment]. New
England Journal of Medicine 332: 1399–1404.
6. Orimadegun A, Amodu O, Olumese P, Omotade O (2008) Early home
treatment of childhood fevers with ineffective antimalarials is deleterious in the
outcome of severe malaria. Malaria Journal 7: 143.
7. Zeidan Z, Kojal H, Habour A, Nowary K, Hashim F, et al. (2006) Clinical and
epidemiological features of severe malaria in children in four hospitals in Sudan.
Eastern Mediterranean Health Journal 12: 783–791.
8. Diallo D, Graz B, Falquet J, Traore AK, Giani S, et al. (2006) Malaria treatment
in remote areas of Mali: use of modern and traditional medicines, patient
outcome. Trans R Soc Trop Med Hyg 100: 515–520.
Risk Factors for Death from Severe Febrile Illness
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e102530
9. Willcox ML, Graz B, Falquet J, Sidibe O, Forster M, et al. (2007) Argemone
mexicana decoction for the treatment of uncomplicated falciparum malaria.
Transactions of the Royal Society of Tropical Medicine & Hygiene 101: 1190–
1198.
10. Graz B, Willcox ML, Diakite C, Falquet J, Dackuo F, et al. (2010) Argemone
mexicana decoction versus artesunate-amodiaquine for the management of
malaria in Mali: policy and public-health implications. Trans R Soc Trop Med
Hyg 104: 33–41.
11. Willcox ML, Graz B, Diakite C, Falquet J, Dackouo F, et al. (2011) Is parasite
clearance clinically important after malaria treatment in a high transmission
area? A 3-month follow-up of home-based management with herbal medicine or
ACT. Transactions of the Royal Society of Tropical Medicine and Hygiene 105:
23–31.
12. Willcox M, Graz B, Falquet J, Diakite C, Giani S, et al. (2011) A ‘‘reverse
pharmacology’’ approach for developing an anti-malarial phytomedicine.
Malaria Journal 10: S8.
13. Willcox ML, Sanogo F, Graz B, Forster M, Dakouo F, et al. (2009) Rapid
diagnostic tests for the home-based management of malaria, in a high-
transmission area. Annals of Tropical Medicine & Parasitology 103: 3–16.
14. Willcox ML, Forster M, Dicko MI, Graz B, Mayon-White R, et al. (2010) Blood
glucose and prognosis in children with presumed severe malaria: is there a
threshold for ‘hypoglycaemia’? Tropical Medicine & International Health 15:
232–240.
15. Ranque S, Poudiougou B, Traore A, Keita M, Oumar AA, et al. (2008) Life-
threatening malaria in African children: a prospective study in a mesoendemic
urban setting. Pediatric Infectious Disease Journal 27: 130–135.
16. Gemperli A, Vounatsou P, Kleinschmidt I, Bagayoko M, Lengeler C, et al.
(2004) Spatial patterns of infant mortality in Mali: the effect of malaria
endemicity. American Journal of Epidemiology 159: 64–72.
17. Rasoanaivo P, Wright C, Willcox M, Gilbert B (2011) Whole plant extracts
versus single compounds for the treatment of malaria: synergy and positive
interactions. Malaria Journal 10: S4.
18. De Francisco A, Schellenberg JA, Hall AJ, Greenwood AM, Cham K, et al.
(1994) Comparison of mortality between villages with and without Primary
Health Care workers in Upper River Division, The Gambia. J Trop Med Hyg
97: 69–74.
19. WHO (2000) Severe falciparum malaria. Transactions of the Royal Society of
Tropical Medicine and Hygiene 94: S1–S90.
20. Schellenberg D, Menendez C, Kahigwa E, Font F, Galindo C, et al. (1999)
African children with malaria in an area of intense Plasmodium falciparum
transmission: features on admission to the hospital and risk factors for death.
American Journal of Tropical Medicine & Hygiene 61: 431–438.
21. Graz B, Dicko M, Willcox ML, Lambert B, Falquet J, et al. (2008) Sublingual
sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
Malaria Journal 7: 242.
22. Biai S, Rodrigues A, Gomes M, Ribeiro I, Sodemann M, et al. (2007) Reduced
in-hospital mortality after improved management of children under 5 years
admitted to hospital with malaria: randomised trial. BMJ 335: 862.
23. Nonvignon J, Aikins MK, Chinbuah MA, Abbey M, Gyapong M, et al. (2010)
Treatment choices for fevers in children under-five years in a rural Ghanaian
district. Malar J 9: 188.
Risk Factors for Death from Severe Febrile Illness
PLOS ONE | www.plosone.org 9 July 2014 | Volume 9 | Issue 7 | e102530
